BROWNSTEIN HYATT FARBER SCHRECK, LLP for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| HAROLD HANCOCK New | Tax Counsel, House Ways and Means Committee |
| JOSEPH BRADY HOWELL New | Treas., Leg. Aff., Sr Adv.; H. For. Aff. Comm., Rep Royce, Asst. Staff Dir., Pol. An., Spec. Asst.; H. Admin. Comm., Rep Miller, Int.; H. For. Aff. Comm., Eur./Eurasia Sub., Rep Burton, Prof. Staff, Rep./Policy Adv., Assoc., Rep.; Rep Burton, Int. |
| DAVID REID New | — |
| ADAM STEINMETZ New | Policy Advisor - Committee on the Budget, United States House of Representatives |
| DEEMA TARAZI New | — |
Taxation/Internal Revenue Code TAX
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| HAROLD HANCOCK New | Tax Counsel, House Ways and Means Committee |
| JOSEPH BRADY HOWELL New | Treas., Leg. Aff., Sr Adv.; H. For. Aff. Comm., Rep Royce, Asst. Staff Dir., Pol. An., Spec. Asst.; H. Admin. Comm., Rep Miller, Int.; H. For. Aff. Comm., Eur./Eurasia Sub., Rep Burton, Prof. Staff, Rep./Policy Adv., Assoc., Rep.; Rep Burton, Int. |
| DAVID REID New | — |
| ADAM STEINMETZ New | Policy Advisor - Committee on the Budget, United States House of Representatives |
| DEEMA TARAZI New | — |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical manufacturing, tax and trade policy affecting the pharmaceutical industry, and the companys expansion of its domestic footprint.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| HAROLD HANCOCK New | Tax Counsel, House Ways and Means Committee |
| JOSEPH BRADY HOWELL New | Treas., Leg. Aff., Sr Adv.; H. For. Aff. Comm., Rep Royce, Asst. Staff Dir., Pol. An., Spec. Asst.; H. Admin. Comm., Rep Miller, Int.; H. For. Aff. Comm., Eur./Eurasia Sub., Rep Burton, Prof. Staff, Rep./Policy Adv., Assoc., Rep.; Rep Burton, Int. |
| DAVID REID New | — |
| ADAM STEINMETZ New | Policy Advisor - Committee on the Budget, United States House of Representatives |
| DEEMA TARAZI New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| MALLINCKRODT PLC | Ireland | Ireland | 100.0% | — |
| MALLINCKRODT INTERNATIONAL FINANCE SA | Luxembourg | Luxembourg | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.